Topic: Risk Communications

Evidence shows that science and scientists remain highly trusted. But genuine scientific voices are not shouting loud enough over the noise to hold sway.

This study used a mixed-methods pre-test-post-test intervention design to test the effectiveness of tailored, context-specific education and community engagement – including community and social media – to increase influenza vaccination uptake in Soweto, South Africa.

We partnered with Wits Vida, the Vaccine Confidence Fund, and PHRU to study how much, if at all, social media and community influencers can influence and increase uptake of influenza vaccines.

Using 5,584 survey responses from people who had received at least one COVID-19 vaccine dose based on a four-round survey between May and November 2022, we examined various factors that affect booster vaccine uptake and the willingness to take an additional shot.

The objective of this systematic review was to examine documented uses and evidence on the effectiveness of conversational AI for vaccine communication.

Heidi Larson, Director of the Vaccine Confidence Project and Professor of Anthropology, Risk and Decision Science and researcher Sara…

The workshop featured a series of presentations – including from VCP Founder and Co-Director Prof. Heidi J Larson – on the nature, mechanisms, and differential impacts of misinformation about science.

These seven learning modules provide tools and skills to support employee vaccination efforts.

This information session hosted by the Steering Group on Influenza Vaccination will aim to introduce the EU Flu Day project and this year’s campaign toolkit, in view of the EU Flu Day 2023 coming up in October.

The UNICEF Regional Office for Europe and Central Asia (UNICEF ECARO) and the VCP worked in partnership to better understand the impact of social media on caregivers’ attitudes, beliefs, trust, immunisation intention and uptake.

This multisite research was designed to harness the power of social media to increase vaccination confidence and uptake in Thailand, Hong Kong, Singapore, and Japan.

Robert Kanwagi, Research Fellow at the VCP, discusses his work over the past six years on introducing an Ebola vaccine…